Regular ArticleSurvival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction
References (25)
- et al.
Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer
Gynecol Oncol
(1999) - et al.
Complications of abdominal operations for malignant disease
Am J Surg
(1988) - et al.
Survival after palliative surgery for advanced intraabdominal cancer
Am J Surg
(1977) - et al.
Palliative surgery for intestinal obstruction in advanced ovarian cancer
Gynecol Oncol
(1989) - et al.
Intestinal operations in patients with ovarian carcinoma
Am J Obstet Gynecol
(1981) - et al.
Surgical management of intestinal obstruction in ovarian cancer. I. Clinical features, postoperative complications, and survival
Gynecol Oncol
(1987) - et al.
The management of ovarian-cancer-caused bowel obstruction
Gynecol Oncol
(1981) - et al.
Survival after ovarian cancer induced intestinal obstruction
Gynecol Oncol
(1982) - et al.
Intestinal obstruction in patients with widespread intraabdominal malignancy
J Pain Symptom Manage
(1992) - et al.
Management of bowel obstruction in cancer patients
Ann Oncol
(1993)
Treatment of bowel obstruction after operation for colorectal carcinoma
Am J Surg
Gastrointestinal emergencies in the critically ill cancer patient
Semin Oncol
Cited by (60)
Considerations in the Management of Malignant Bowel Obstruction
2021, Surgical Oncology Clinics of North AmericaPeritoneal Cancers and Hyperthermic Intraperitoneal Chemotherapy
2020, Surgical Clinics of North AmericaCitation Excerpt :Median survival after diagnosis of MBO ranges from 26 to 273 days, and can be differentiated for 2 distinct patient populations, labeled as high or low risk.109 Overall median survival after the surgical intervention was 64 to 112 days for all patients with MBO.105,107,110 Patients with no associated ascites or palpable mass who had return of bowel function in the postoperative period survived between 154 and 192 days versus 26 to 36 days in patients with ascites, palpable mass, and slow return of bowel function.109
Survival Outcomes After Surgical Management of the Primary Tumor With and Without Radiotherapy for Metastatic Rectal Adenocarcinoma: A National Cancer Database (NCDB) Analysis
2019, Clinical Colorectal CancerCitation Excerpt :However, postoperative complications in patients with metastatic colorectal cancer tend to be minimal in the modern era with laparoscopic techniques,27,28 and perioperative mortality in the metastatic setting is less then 2%.29 Furthermore, planned elective rather than emergent surgery resection may lower perioperative mortality and contribute to improved outcomes.15,30 Although the distinct survival benefit with the addition of pelvic radiotherapy to primary tumor resection in the metastatic setting is hypothesis-generating, it must be considered with the selection bias inherent to any large retrospective study.
Acute Abdomen, Bowel Obstruction, and Fistula
2019, Abeloff’s Clinical OncologyMalignant Bowel Obstruction: Reappraising the Value of Surgery
2018, Surgical Oncology Clinics of North AmericaRecommendations for bowel obstruction with peritoneal carcinomatosis
2014, Journal of Pain and Symptom Management
- f1
Correspondence to: Hugues Legendre, Department of Surgery, Jules Bordet, 1 Rue Héger-Bordet, B-1000 – Brussels, Belgium. Tel: +32 (0)2 541 31 52; Fax: +32 (02) 541 31 41; E-mail: hugues.legendre@ bordet.be